NDC 62135-302

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-302Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0302Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62135-302-24	62135030224	2 TRAY in 1 BOX (62135-302-24) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (62135-302-05)Marketed from Oct 16, 2024
62135-302-47	62135030247	473 mL in 1 BOTTLE (62135-302-47)Marketed from Jan 23, 2023
62135-302-48	62135030248	118 mL in 1 BOTTLE (62135-302-48)Marketed from Jan 23, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide
Generic name (nonproprietary): brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide
Active ingredients: Brompheniramine maleate — 2 mg/5mLPseudoephedrine hydrochloride — 30 mg/5mLDextromethorphan hydrobromide — 10 mg/5mL
Dosage form: Syrup
Route: Oral
Labeler: Chartwell RX, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213125
Marketing start: Apr 17, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Sigma-1 Receptor Agonists (Mechanism)Uncompetitive NMDA Receptor Antagonists (Mechanism)
Identifiers: Product ID 62135-302_2501201a-b3e6-cc4d-e063-6394a90a482fSPL ID 2501201a-b3e6-cc4d-e063-6394a90a482fSPL set ID 30f0317c-4793-4b88-8c06-c0f3cb12b3eaRxCUI 1357010UNII IXA7C9ZN03, 6V9V2RYJ8N, 9D2RTI9KYHUPC 0362135302481, 0362135302474
Pharmacologic class: Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist; alpha-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135030224 followed by a unit qualifier and the quantity

Package 62135-0302-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 21, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE For relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213125

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213125
Product	Strength	Form · route	Labeler	Product NDC
Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide	Brompheniramine maleate 2 mg/5mL + 2 more ingredients	SyrupOral	Chartwell Governmental & Specialty RX, LLC	68999-302

Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide NDC 62135-302